Recursion Pharmaceuticals, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
RXRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
41 S Rio Grande Street, Salt Lake City, Utah

Insiders trading volume in the past year

Recursion Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Lux Ventures IV, L.P. Former 10% Owner $138M Dec 7, 2021
Investment Co PJSC Mubadala More than 10% owner $137M Mar 2, 2023
Blake Borgeson Director $65.9M -$3.47M -5% May 28, 2024
Zachary Bogue Director, More than 10% owner $39.5M Jul 3, 2023
Christopher Gibson Chief Executive Officer, Director $30M -$8.11M -21.3% May 15, 2024
Dean Y. Li Director $28M -$396K -1.4% Apr 1, 2024
MIC Capital Partners (Public) Parallel Cayman, LP More than 10% owner $14.7M Nov 1, 2021
Michael Secora Chief Financial Officer $12.2M -$5.1M -29.5% May 15, 2024
Tina Marriott President and COO $5.34M -$613K -10.3% May 15, 2024
David J. Mauro Chief Medical Officer $2.44M May 15, 2024
Shafique Virani Chief Business Officer $1.45M -$2.83M -66.2% Jan 16, 2024
Ramona Doyle Chief Medical Officer $1.28M May 16, 2022
Zavain Dar Director $785K -$181K -18.8% Apr 1, 2024
Chavez R. Martin Director $530K Apr 1, 2024
Terry-Ann Burrell Director $497K -$1.41M -74% Apr 1, 2024
Robert Hershberg Director $408K Jun 16, 2023
Mic Capital Partners (Public) (Us) Im, Llc Other* Nov 1, 2021
Najat Khan Director Apr 16, 2024

Recent Insider Transactions by Companies or Individuals for Recursion Pharmaceuticals, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership